CRSP - CRISPR Therapeutics (CRSP) Presents at Goldman Sachs 45th Annual Global Healthcare Conference - Company Call Transcript
2024-06-11 12:32:06 ET
CRISPR Therapeutics AG (CRSP)
Company Conference Call
June 11, 2024 9:20 am ET
Company Participants
Sam Kulkarni - Chief Executive Officer
Conference Call Participants
Salveen Richter - Goldman Sachs
Presentation
Salveen Richter
Good afternoon everyone, thank you for joining us. Really pleased to have Sam Kulkarni, CEO of CRISPR Therapeutics here with us.
Sam, perhaps to start here, you have a couple of verticals - you have cancer, ex-vivo non-cancer, regenerative medicine, and in vivo verticals. Can you discuss how you’re prioritizing across the pipeline in addition to capital allocation, and how you leverage R&D across these separate verticals?
Sam Kulkarni
Yes, thank you for having us here, Salveen. As a company, we’ve been shaping our portfolio over the last nine years in the company’s journey, and there were a couple of different elements that went into where we ended up today on the portfolio. One is the key question of where can CRISPR be the most transformative and powerful from a technology standpoint, and two is what are the diseases we want to impact. ...
CRISPR Therapeutics (CRSP) Presents at Goldman Sachs 45th Annual Global Healthcare Conference - Company Call Transcript